References
Bohm J, Bulla M, Urquhart JE, Malfatti E, Williams SG, O’Sullivan J, Szlauer A, Koch C, Baranello G, Mora M et al (2017) ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy. Hum Mutat. doi:10.1002/humu.23172
Bohm J, Chevessier F, Maues De Paula A, Koch C, Attarian S, Feger C, Hantai D, Laforet P, Ghorab K, Vallat JM et al (2013) Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet 92:271–278. doi:10.1016/j.ajhg.2012.12.007S0002-9297(12)00641-6
Chevessier F, Bauche-Godard S, Leroy JP, Koenig J, Paturneau-Jouas M, Eymard B, Hantai D, Verdiere-Sahuque M (2005) The origin of tubular aggregates in human myopathies. J Pathol 207:313–323. doi:10.1002/path.1832
Damiani E, Salvatori S, Margreth A (1990) Characterization of calsequestrin of avian skeletal muscle. J Muscle Res Cell Motil 11:48–55
Lewis KM, Ronish LA, Rios E, Kang C (2015) Characterization of two human skeletal calsequestrin mutants implicated in malignant hyperthermia and vacuolar aggregate myopathy. J Biol Chem 290:28665–28674. doi:10.1074/jbc.M115.686261
Manno C, Figueroa LC, Gillespie D, Fitts R, Kang C, Franzini-Armstrong C, Rios E (2017) Calsequestrin depolymerizes when calcium is depleted in the sarcoplasmic reticulum of working muscle. Proc Natl Acad Sci USA 114:E638–E647. doi:10.1073/pnas.1620265114
Nesin V, Wiley G, Kousi M, Ong EC, Lehmann T, Nicholl DJ, Suri M, Shahrizaila N, Katsanis N, Gaffney PM et al (2014) Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc Natl Acad Sci USA 111:4197–4202. doi:10.1073/pnas.1312520111
Rohkamm R, Boxler K, Ricker K, Jerusalem F (1983) A dominantly inherited myopathy with excessive tubular aggregates. Neurology 33:331–336
Rossi D, Vezzani B, Galli L, Paolini C, Toniolo L, Pierantozzi E, Spinozzi S, Barone V, Pegoraro E, Bello L et al (2014) A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates. Hum Mutat 35:1163–1170. doi:10.1002/humu.22631
Acknowledgements
We thank the members of the families for their interest in this study, Wolfram Kress, Michel Fardeau, and Daniel Hantaï for material transfer, and Catherine Koch, Anaïs Chanut, and Raphaël Schneider for their valuable technical assistance. This work was funded by INSERM, CNRS, University of Strasbourg, Agence Nationale de la Recherche (ANR-11-BSV1-026, ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002, and FRISBI ANR-10-INBS-05), Fondation Maladies Rares, Association Française contre les Myopathies (AFM-17088), the Muscular Dystrophy Association (MDA-186985), and the Swiss National Science Foundation (323530_158118 to MB). The EuroBioBank and Telethon Network of Genetic Biobanks (GTB12001F to MM) are gratefully acknowledged for providing biological samples.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Böhm, J., Lornage, X., Chevessier, F. et al. CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy. Acta Neuropathol 135, 149–151 (2018). https://doi.org/10.1007/s00401-017-1775-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-017-1775-x